NFE2L1 and liver cancer: Lee et al. showed that mitochondrial respiratory defects mediated NFE2L1 upregulation, which promotes the expression of its effective downstream target syntaxin 12 (STX12), a key regulator of cancer progression in several liver cancer cell lines [23].